SCHEMBL29964237

SCHEMBL29964237

CN(C)Cc1cc(-c2cc(-c3cc4c(cc3F)C(=O)NCC4)c(N)nc2F)ccc1OC1CCNCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
CD274 Q9NZQ7 1/20 0.34
MAPK1 P28482 1/20 0.33
MAPKAPK2 P49137 2/20 0.33
IKBKB O14920 5/20 0.32
CHUK O15111 5/20 0.32
ROCK1 Q13464 2/20 0.32
LCK P06239 1/20 0.32
AKT1 P31749 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
BCL9 O00512 2/20 0.31
CTNNB1 P35222 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
PIM1 P11309 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964381 0.92 MAPK1 (0.40) ALOX5APFEN1CD274MAPK1MAPKAPK2
SCHEMBL29964735 0.91 MAPK1 (0.41) ALOX5APFEN1MAPK1MAPKAPK2IKBKB
SCHEMBL29964819 0.90 IKBKB (0.36) ALOX5APFEN1CD274IKBKBCHUK
SCHEMBL31079253 0.89 CD274 (0.42) CD274MAPK1MAPKAPK2GABRG2GABRB3
SCHEMBL31079278 0.88 MAPK1 (0.35) ALOX5APFEN1CD274MAPK1MAPKAPK2
SCHEMBL31079113 0.88 MAPKAPK2 (0.35) CD274MAPK1MAPKAPK2GABRG2GABRB3
SCHEMBL29964559 0.87 CD274 (0.36) CD274MAPK1MAPKAPK2GABRG2GABRB3
SCHEMBL31079204 0.85 MAPK1 (0.41) CD274MAPK1GABRG2GABRB3GABRA5
SCHEMBL29963684 0.85 TBK1 (0.40) ALOX5APFEN1
SCHEMBL29963981 0.85 CD274 (0.35) CD274MAPK1MAPKAPK2GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 ALOX5AP 4225/4885FEN1 2836/4885CD274 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.